all

The NLA Recommendations for Patient-Centered Management of Dyslipidemia was recently published in the Journal of Clinical Lipidology. As you know, these Recommendations are a tool for clinicians who treat patients with dyslipidemia — and they should serve as guidance for treatment. To ensure that the NLA Recommendations are successful and reach as many clinicians as possible, we need your help and involvement! 

By Carl E. Orringer

A 55-year-old South Asian Indian physician comes to you for management recommendations for primary prevention of atherosclerotic cardiovascular disease (ASCVD). He has no current cardiovascular symptoms.

He has an eight-year history of well-controlled arterial hypertension, for which he has been treated with lisinopril 10 mg daily. He is a nonsmoker, has no history of diabetes and has never taken treatment for a lipid disorder. His father had an MI at age 52.

From Cardiovascular Business:

By Candace Stuart

The National Lipid Association (NLA) published recommendations that are designed to help fill the gaps in the 2013 cholesterol guidelines jointly released by two cardiology associations. The report aligns with some aspects of the guidelines but diverges on cholesterol targets.